Table 1. ALAD tagging Single Nucleotide Polymorphisms (SNPs) evaluated in the Central Eastern European Renal Cancer Study.

Chromosome location	Location of Nucleotide Change	Amino Acid Change	dbSNP ID	Minor allele frequency in control population	Assay (Golden Gate or Taqman)
9q33	g.-22966C>T		rs14419	0.36	GoldenGate
	g.-19563T>A		rs818694	0.30	GoldenGate
9q32	g.IVS1+1425G>C		rs818688	0.37	GoldenGate
	g.IVS1+2615G>T		rs818687	0.18	GoldenGate
	g.IVS1−3185G>A		rs2792818	0.17	GoldenGate
	g.IVS2+299C>T		rs8177796	0.08	GoldenGate
	g.IVS3−196G>A		rs8177800	0.08	GoldenGate
	Ex4+13G>C	K68N	rs1800435	0.08	Taqman
	g.IVS4−139G>A		rs2761016	0.44	GoldenGate
	g.Ex6+17C>T	N147N	rs2228083	0.11	GoldenGate
	g.IVS11+66T>C		rs1805313	0.38	GoldenGate
	g.Ex12+533C>T		rs818708	0.44	GoldenGate
	g.Ex12+675G>A		rs818707	0.10	GoldenGate
	g.Ex12+100C>G		rs818705	0.18	GoldenGate
	g.Ex12+277C>T		rs818704	0.13	GoldenGate
	g.Ex12+352C>T		rs7042485	0.29	GoldenGate
	g.6440T>C		rs16933168	0.16	GoldenGate
	g.7758C>T		rs16936474	0.16	GoldenGate
	g.8429C>G		rs3750526	0.09	GoldenGate